Yevgeniya Abramzon

10.6k total citations
7 papers, 506 citations indexed

About

Yevgeniya Abramzon is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Yevgeniya Abramzon has authored 7 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Yevgeniya Abramzon's work include Neurogenetic and Muscular Disorders Research (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurological diseases and metabolism (3 papers). Yevgeniya Abramzon is often cited by papers focused on Neurogenetic and Muscular Disorders Research (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Neurological diseases and metabolism (3 papers). Yevgeniya Abramzon collaborates with scholars based in United States, United Kingdom and Italy. Yevgeniya Abramzon's co-authors include Bryan J. Traynor, Ruth Chia, Pietro Fratta, Adriano Chiò, Janel O. Johnson, Andrea Calvo, Gabriella Restagno, Maura Brunetti, Andrew Singleton and A. Reghan Foley and has published in prestigious journals such as Brain, Science Advances and Neurobiology of Aging.

In The Last Decade

Yevgeniya Abramzon

7 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yevgeniya Abramzon United States 6 327 216 161 112 71 7 506
Viviana Pensato Italy 12 280 0.9× 182 0.8× 199 1.2× 149 1.3× 176 2.5× 26 530
Janel O. Johnson United States 10 163 0.5× 153 0.7× 73 0.5× 66 0.6× 94 1.3× 11 364
Tijs Vandoorne Belgium 9 377 1.2× 325 1.5× 220 1.4× 63 0.6× 111 1.6× 12 648
Pamela Keagle United States 9 433 1.3× 249 1.2× 253 1.6× 100 0.9× 69 1.0× 9 543
Gloria M. Palomo United States 8 205 0.6× 300 1.4× 60 0.4× 53 0.5× 107 1.5× 11 537
Reika Wate Japan 13 531 1.6× 319 1.5× 263 1.6× 109 1.0× 133 1.9× 27 707
Maria Rosaria Monsurrò Italy 12 424 1.3× 248 1.1× 269 1.7× 92 0.8× 96 1.4× 14 604
Ruxandra Dafinca United Kingdom 9 453 1.4× 367 1.7× 231 1.4× 91 0.8× 141 2.0× 15 636
Christelle Tesson France 10 208 0.6× 196 0.9× 50 0.3× 124 1.1× 211 3.0× 17 496
Elena Sánchez-Ferrero Spain 8 86 0.3× 161 0.7× 60 0.4× 101 0.9× 164 2.3× 10 313

Countries citing papers authored by Yevgeniya Abramzon

Since Specialization
Citations

This map shows the geographic impact of Yevgeniya Abramzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yevgeniya Abramzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yevgeniya Abramzon more than expected).

Fields of papers citing papers by Yevgeniya Abramzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yevgeniya Abramzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yevgeniya Abramzon. The network helps show where Yevgeniya Abramzon may publish in the future.

Co-authorship network of co-authors of Yevgeniya Abramzon

This figure shows the co-authorship network connecting the top 25 collaborators of Yevgeniya Abramzon. A scholar is included among the top collaborators of Yevgeniya Abramzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yevgeniya Abramzon. Yevgeniya Abramzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sáez-Atiénzar, Sara, Sara Bandrés‐Ciga, Rebekah G. Langston, et al.. (2021). Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Science Advances. 7(3). 58 indexed citations
2.
Abramzon, Yevgeniya, Pietro Fratta, Bryan J. Traynor, & Ruth Chia. (2020). The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Neuroscience. 14. 42–42. 165 indexed citations
3.
Caress, James B., Janel O. Johnson, Yevgeniya Abramzon, et al.. (2016). Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar‐onset neuropathy. Muscle & Nerve. 56(5). 1001–1005. 5 indexed citations
4.
Johnson, Janel O., J. Raphael Gibbs, André Mégarbané, et al.. (2012). Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain. 135(9). 2875–2882. 99 indexed citations
5.
Majounie, Elisa, Yevgeniya Abramzon, Alan E. Renton, et al.. (2012). Large C9orf72 repeat expansions are not a common cause of Parkinson's disease. Neurobiology of Aging. 33(10). 2527.e1–2527.e2. 34 indexed citations
6.
Abramzon, Yevgeniya, Janel O. Johnson, Sonja W. Scholz, et al.. (2012). Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiology of Aging. 33(9). 2231.e1–2231.e6. 84 indexed citations
7.
Chiò, Adriano, Andrea Calvo, Cristina Moglia, et al.. (2010). A de novo missense mutation of the FUS gene in a “true” sporadic ALS case. Neurobiology of Aging. 32(3). 553.e23–553.e26. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026